Xenonics Reports Third Quarter Results

Xenonics Reports Third Quarter Results

CARLSBAD, Calif.--(BUSINESS WIRE)-- XENONICS HOLDINGS, INC. (OTCBB:XNNH) today announced financial results for the third quarter and first nine months of fiscal 2013.

Revenue for the three months ended June 30, 2013 decreased to $373,000, compared to $403,000 for the third quarter of fiscal 2012. The net loss for the third quarter of fiscal 2013 was $480,000, or $0.02 per share. This compares to a net loss for the third quarter of fiscal 2012 of $630,000, or $0.03 per share.


For the nine months ended June 30, 2013, revenue increased to $1,492,000, compared to $1,200,000 for the first nine months of fiscal 2012. The net loss for this year's first nine months decreased to $1,267,000, or $0.05 per share. This compares to a net loss for the first nine months of fiscal 2012 of $1,857,000, or $0.07 per share.

Selling, general and administrative expenses decreased by 28% to $380,000 for the third quarter of fiscal 2013 from $527,000 for the third quarter of fiscal 2012. For the first nine months, SG&A decreased to $1,264,000, compared to $1,587,000 for the same period of the prior fiscal year.

At June 30, 2013, Xenonics reported total current assets of $2,030,000, including cash of $185,000, accounts receivable of $60,000, and inventories of $1,740,000. Total current liabilities at June 30, 2013 of $2,510,000 included notes payable of $1,898,000 due in October 2013.

"We expect to ship in the current quarter approximately $900,000 of the $1.2 million NightHunter purchase order we received from Aardvark Tactical last May. We are pursuing additional orders for our NightHunter and SuperVision products," said Chairman Alan Magerman.

Conference Call

Xenonics has scheduled a conference call at 11:00 a.m. EDT this morning to discuss its results for the third quarter of fiscal 2013. The dial-in number is (877) 703-6109, passcode #72336076. A simultaneous webcast of the conference call can be accessed from the Webcast Center of the Investor Relations link at www.xenonics.com. A replay will be available after 1:00 p.m. EDT at this same Internet address. For a telephone replay, dial (888) 286-8010, passcode #73595683, after 1:00 p.m. EDT.

About Xenonics

Xenonics Holdings, Inc. develops and produces advanced, lightweight and compact ultra-high-intensity illumination and low-light vision products for military, law enforcement, public safety, and commercial and private sector applications. Xenonics' NightHunter line of illumination products is used by every branch of the U.S. Armed Forces as well as law enforcement and security agencies. Its SuperVision high-definition night vision is designed for commercial and military applications. Employing patented technologies, Xenonics provides innovative solutions for customers who must see farther so they can do their jobs better and safer. Xenonics' products represent the next generation in small, high intensity, high efficiency illumination and low-light vision systems. Visit Xenonics on the web at www.xenonics.com.

Forward-Looking Statements

Except for the historical statements, statements in this release may constitute forward-looking statements within the meaning of section 21E of the Securities Exchange Act of 1934.When used, the words "anticipates," "believes," "expects," "intends," "future," and other similar expressions identify forward-looking statements.These forward-looking statements reflect management's current views with respect to future events and financial performance and are subject to risks and uncertainties, and actual results may differ materially from the outcomes contained in any forward-looking statement.Factors that could cause these forward-looking statements to differ from actual results include delays in development, marketing or sales of new products, and other risks and uncertainties discussed in the company's periodic reports on Form 10-K and 10-Q and other filings with the Securities and Exchange Commission.Xenonics Holdings undertakes no obligation to update or revise any forward-looking statements.

XENONICS HOLDINGS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

Three months ended

Nine months ended

June 30,

June 30,

2013

2012

2013

2012

Rounded in thousands, except per share amounts

(unaudited)

(unaudited)

Revenue

$

373,000

$

403,000

$

1,492,000

$

1,200,000

Cost of goods sold

247,000

254,000

826,000

741,000

Gross profit

126,000

149,000

666,000

459,000

Selling, general and administrative

380,000

527,000

1,264,000

1,587,000

Research and development

99,000

191,000

327,000

588,000

Income (loss) from operations

(353,000

)

(569,000

)

(925,000

)

(1,716,000

)

Other income (expense):

Interest (expense)

(127,000

)

(61,000

)

(340,000

)

(139,000

)

(Loss) before provision for income taxes

(480,000

)

(630,000

)

(1,265,000

)

(1,855,000

)

Income tax provision

--

--

2,000

2,000

Net (loss)

$

(480,000

)

$

(630,000

)

$

(1,267,000

)

$

(1,857,000

)

Net income (loss) per share:

Basic

$

(0.02

)

$

(0.03

)

$

(0.05

)

$

(0.07

)

Fully-diluted

$

(0.02

)

$

(0.03

)

$

(0.05

)

$

(0.07

)

Weighted average shares outstanding:

Basic

24,976,000

24,976,000

24,976,000

24,976,000

Fully diluted

24,976,000

24,976,000

24,976,000

24,976,000

XENONICS HOLDINGS, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

June 30,

September 30,

2013

2012

Rounded in thousands, except par value

(unaudited)

Assets

Current Assets:

Cash

$

185,000

$

367,000

Accounts receivable

60,000

58,000

Inventories

1,740,000

2,117,000

Other current assets

45,000

82,000

Total Current Assets

2,030,000

2,624,000

Equipment, furniture and fixtures, net

14,000

14,000

Goodwill

375,000

375,000

Other assets

17,000

17,000

Total Assets

$

2,436,000

$

3,030,000

Liabilities and Shareholders' Equity

Current Liabilities:

Accounts payable

$

360,000

$

281,000

Accrued expenses

191,000

134,000

Accrued payroll and related taxes

61,000

95,000

Notes payable, net of debt discount

1,898,000

1,000,000

Total Current Liabilities

2,510,000

1,510,000

Notes payable

--

525,000

Total Liabilities

2,510,000

2,035,000

Commitments and contingencies

Shareholders' Equity:

Preferred shares, $0.001 par value, 5,000,000

shares authorized, 0 shares issued and outstanding

--

--

Common shares, $0.001 par value, 50,000,000

shares authorized; 24,976,000 shares issued and

outstanding at June 30, 2013 and September 30, 2012

25,000

25,000

Additional paid-in capital

26,879,000

26,681,000

Accumulated deficit

(26,978,000

)

(25,711,000

)

Total Shareholders' Equity (Deficit)

(74,000

)

995,000

Total Liabilities and Shareholders' Equity

$

2,436,000

$

3,030,000

anImage
anImage



Investor Contact:
Berkman Associates
(310) 477 - 3118
info@BerkmanAssociates.com
or
Company Contact:
Xenonics Holdings, Inc.
Alan Magerman, Chairman
(760) 477 - 8900
xenonics@xenonics.com

KEYWORDS: United States North America California

INDUSTRY KEYWORDS:

The article Xenonics Reports Third Quarter Results originally appeared on Fool.com.

Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.